# FDA 483 - AGC Biologics, Inc. - February 10, 2023

Source: https://www.keypedia.com/records/483/agc-biologics-inc/29068fb0-b901-4b27-8d6c-480f07b9d85d

> FDA 483 for AGC Biologics, Inc. on February 10, 2023. Product: N/A. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AGC Biologics, Inc.
- Inspection Date: 2023-02-10
- Office Name: Office of Regulatory Affairs

## Related Documents

- [483 - Unknown Date](https://www.keypedia.com/records/483/agc-biologics-inc/361f2f05-4042-44c5-985a-e95863e25cc0)
- [483 - Unknown Date](https://www.keypedia.com/records/483/agc-biologics-inc/f364fb7c-8e0e-47cb-905e-2ec30672b2c1)
- [EIR - 2021-03-19](https://www.keypedia.com/records/eir/agc-biologics-inc/7a3e7ea1-7f89-4fff-9f88-dade096c5e9f)
- [483 - 2025-04-18](https://www.keypedia.com/records/483/agc-biologics-inc/5feb9b19-4203-4a42-8153-4c5ad2c4aa43)
- [483 - 2023-02-10](https://www.keypedia.com/records/483/agc-biologics-inc/642c5042-ad56-4c71-91da-5d256a20fc36)

Company: https://www.keypedia.com/companies/agc-biologics-inc/9759f733-dd5f-4f2e-a516-f1b37fad39e2

Office: https://www.keypedia.com/offices/office-of-regulatory-affairs/ff91c598-cf72-4dbe-a2c8-7519c64cbc64